Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome

Brain, Behavior, and Immunity

Volumn 26, Issue 8, 2012, Pages 1239-1243

  Trotti, Lynn Marie ^a   Rye, David B ^a   Staercke, Christine De ^b   Hooper, W Craig ^b   Quyyumi, Arshed ^a   Bliwise, Donald L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

C reactive protein; Cardiovascular disease; Interleukin 6; Periodic leg movements of sleep; Restless legs syndrome; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RISK FACTOR;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MOVEMENT; RESTLESS LEGS SYNDROME; SLEEP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867203813     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.06.003     Document Type: Article

References (46)

1. AASM (Ed.), 2005. International classification of sleep disorders: diagnositic and coding manual (ICSD-2), Westchester.
2. Aksu M., Demirci S., Bara-Jimenez W. Correlation between putative indicators of primary restless legs syndrome severity. Sleep Med. 2007, 8:84-89.
3. Bajpai A., Goyal A., Sperling L. Should we measure C-reactive protein on earth or just on JUPITER?. Clin. Cardiol. 2010, 33:190-198.
4. Bekci T.T., Kayrak M., Kiyici A., Ari H., Teke T., Maden E., Akilli H. The relation between Lp-PLA2 levels with periodic limb movements. Sleep Breath 2012, 16:117-122.
5. Benediktsdottir B., Janson C., Lindberg E., Arnardottir E.S., Olafsson I., Cook E., Thorarinsdottir E.H., Gislason T. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med. 2010, 11:1043-1048.
6. Berger K., von Eckardstein A., Trenkwalder C., Rothdach A., Junker R., Weiland S.K. Iron metabolism and the risk of restless legs syndrome in an elderly general population-the MEMO-Study. J. Neurol. 2002, 249:1195-1199.
7. Billars L., Hicks A., Bliwise D., Sigmundsson T., Sigurdsson A., Kristjansson K., Gulcher J., Stefansson K., Rye D. Hypertension risk and PLMS in restless legs syndrome. Sleep 2007, 30:A297-A298.
8. Casas J.P., Shah T., Hingorani A.D., Danesh J., Pepys M.B. C-reactive protein and coronary heart disease: a critical review. J. Intern. Med. 2008, 264:295-314.
9. Ciftci T.U., Kokturk O., Bukan N., Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004, 28:87-91.
10. Cosentino F.I., Arico D., Lanuzza B., Raggi A., Sciortino G., Tripodi M., Bella R., Zucconi M., Ferri R. Absence of cardiovascular disease risk factors in restless legs syndrome. Acta Neurol. Scand. 2012, 125:319-325.
11. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., Wensley F., Higgins J.P., Lennon L., Eiriksdottir G., Rumley A., Whincup P.H., Lowe G.D., Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008, 5:e78.
12. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 2004, 350:1387-1397.
13. Ebrahimi M., Ghayour-Mobarhan M., Rezaiean S., Hoseini M., Parizade S.M., Farhoudi F., Hosseininezhad S.J., Tavallaei S., Vejdani A., Azimi-Nezhad M., Shakeri M.T., Rad M.A., Mobarra N., Kazemi-Bajestani S.M., Ferns G.A. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol. 2009, 64:321-327.
14. Ferri R., Zucconi M., Rundo F., Spruyt K., Manconi M., Ferini-Strambi L. Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep. Clin. Neurophysiol. 2007, 118:438-448.
15. Garcia-Borreguero D., Larrosa O., de la Llave Y., Granizo J.J., Allen R. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med. 2004, 5:561-565.
16. Guggisberg A.G., Hess C.W., Mathis J. The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep. Sleep 2007, 30:755-766.
17. Ho G.Y., Xue X.N., Burk R.D., Kaplan R.C., Cornell E., Cushman M. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2years in young women. Cytokine 2005, 30:1-6.
18. Innes K.E., Selfe T.K., Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med. Rev. 2012, 16:309-339.
19. Jelic S., Padeletti M., Kawut S.M., Higgins C., Canfield S.M., Onat D., Colombo P.C., Basner R.C., Factor P., LeJemtel T.H. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278.
20. Koo B.B., Blackwell T., Ancoli-Israel S., Stone K.L., Stefanick M.L., Redline S. Association of incident cardiovascular disease with periodic limb movements during sleep in older men: outcomes of sleep disorders in older men (MrOS) study. Circulation 2011, 124:1223-1231.
21. Lange T., Dimitrov S., Born J. Effects of sleep and circadian rhythm on the human immune system. Ann. N. Y. Acad. Sci. 2010, 1193:48-59.
22. Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83:456S-460S.
23. Manconi M., Ferri R., Zucconi M., Clemens S., Rundo F., Oldani A., Ferini-Strambi L. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep. Sleep Med. 2011, 12:47-55.
24. Meier-Ewert H.K., Ridker P.M., Rifai N., Price N., Dinges D.F., Mullington J.M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin. Chem. 2001, 47:426-430.
25. Muhlestein J.B. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb. Haemost. 2010, 103:71-82.
26. Payette C., Blackburn P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., Despres J.P., Couillard C. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 2009, 58:1593-1601.
27. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
28. Pennestri M.H., Montplaisir J., Colombo R., Lavigne G., Lanfranchi P.A. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007, 68:1213-1218.
29. Petrovsky N. Whole blood assays and the influence of circadian rhythmicity on human cytokine measurement. Methods in Molecular Medicine, volume 60: Interleukin Protocols 2001, Humana Press, Inc., Totowa, NJ. L.A.J. O'Neill, A. Bowie (Eds.).
30. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc. Drug Rev. 2006, 24:33-50.
31. Ryan S., Taylor C.T., McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 2006, 174:824-830.
32. Sarwar N., Thompson A.J., Di Angelantonio E. Markers of inflammation and risk of coronary heart disease. Dis. Markers 2009, 26:217-225.
33. Sforza E., Pichot V., Barthelemy J.C., Haba-Rubio J., Roche F. Cardiovascular variability during periodic leg movements: a spectral analysis approach. Clin. Neurophysiol. 2005, 116:1096-1104.
34. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., Somers V.K. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
35. Siddiqui F., Strus J., Ming X., Lee I.A., Chokroverty S., Walters A.S. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin. Neurophysiol. 2007, 118:1923-1930.
36. Siddiqui F., Strus J., Sun Y.J., Walters A.S. No significant difference in cytokine levels in patients with restless legs syndrome versus controls - preliminary data. Sleep Med. 2007, 8:98-99.
37. Stefansson H., Rye D.B., Hicks A., Petursson H., Ingason A., Thorgeirsson T.E., Palsson S., Sigmundsson T., Sigurdsson A.P., Eiriksdottir I., Soebech E., Bliwise D., Beck J.M., Rosen A., Waddy S., Trotti L.M., Iranzo A., Thambisetty M., Hardarson G.A., Kristjansson K., Gudmundsson L.J., Thorsteinsdottir U., Kong A., Gulcher J.R., Gudbjartsson D., Stefansson K. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med. 2007, 357:639-647.
38. Steiropoulos P., Papanas N., Nena E., Antoniadou M., Serasli E., Papoti S., Hatzizisi O., Kyriazis G., Tzouvelekis A., Maltezos E., Tsara V., Bouros D. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?. Mediators Inflamm. 2010, 2010:675320.
39. Svatikova A., Wolk R., Shamsuzzaman A.S., Kara T., Olson E.J., Somers V.K. Serum amyloid a in obstructive sleep apnea. Circulation 2003, 108:1451-1454.
40. Trotti L.M., Bliwise D.L., Greer S.A., Sigurdsson A.P., Gudmundsdottir G.B., Wessel T., Organisak L.M., Sigthorsson T., Kristjansson K., Sigmundsson T., Rye D.B. Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis. Sleep Med. 2009, 10:668-671.
41. Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106:1439-1441.
42. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 1997, 82:1313-1316.
43. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am. J. Epidemiol. 2007, 165:710-718.
44. Weinstock L.B., Walters A.S., Paueksakon P. Restless legs syndrome - theoretical roles of inflammatory and immune mechanisms. Sleep Med. Rev. 2012, 16:341-354.
45. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
46. Zhang H., Park Y., Wu J., Chen X., Lee S., Yang J., Dellsperger K.C., Zhang C. Role of TNF-alpha in vascular dysfunction. Clin. Sci. (London) 2009, 116:219-230.